Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann N Y Acad Sci. 2008 Dec;1150:220-9. doi: 10.1196/annals.1447.048.

Autologous hematopoietic stem cell transplantation for type 1 diabetes.

Author information

1
Department of Clinical Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil. jcvoltar@fmrp.usp.br

Abstract

In this review, we present (1) the scientific basis for the use of high-dose immunosuppression followed by autologous peripheral blood hematopoietic stem cell transplantation for newly diagnosed type 1 diabetes (T1D); (2) an update of the clinical and laboratory outcome of 20 patients transplanted at the University Hospital of the Ribeirão Preto Medical School, University of São Paulo, Brazil, and followed up to January/2008, including 4 relapses among 19 patients without previous ketoacidosis; (3) a commentary on criticisms to our article that appeared in four articles from the scientific literature; and (4) a discussion of the prospectives for cellular therapy for T1D.

PMID:
19120300
DOI:
10.1196/annals.1447.048
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center